Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 192.97

-1.6%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (20501)	6/1/1998 5:30:00 PM
From: Machaon	Read Replies (1) of 32384

<< "We believe that ONTAK represents an important therapeutic option for patients with CTCL and their physicians, and we look forward to our upcoming review with the ODAC," said Jean Nichols, Ph.D., Seragen President and Chief Technology Officer. "We are pleased that if successful in gaining FDA approval, we will be able to provide through Ligand a rapid availability of ONTAK to CTCL patients in the U.S. and abroad, a goal many of us at Seragen have pursued for many years." >> Many years of work went into the development of ONTAK. Tomorrow is a big day for those who have worked on it. << If approved, ONTAK will be recognized as the first of a new class of cytotoxic biologic agents - a fusion protein. >> Here's hoping that the ODAC gives a favorable ruling. ONTAK could open the door to many other products. By the way, I just visited your website, again. I wanted to find out more info about tomorrow's ODAC meetings, and had no problems locating what I was looking for. Ligand should give you royalties on their products! <g> Good luck, Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next